688185 康希诺
已收盘 10-22 15:00:00
资讯
新帖
简况
破发股康希诺跌6.74% 2020年上市募52亿元中信证券保荐
中金财经 · 10-22 16:06
破发股康希诺跌6.74% 2020年上市募52亿元中信证券保荐
康希诺:定期报告截止日及其后的股东人数披露不早于当期定期报告的披露
证券之星 · 10-20 16:45
康希诺:定期报告截止日及其后的股东人数披露不早于当期定期报告的披露
康希诺(688185)10月19日主力资金净卖出9719.98万元
证券之星 · 10-20 08:30
康希诺(688185)10月19日主力资金净卖出9719.98万元
康希诺(688185)10月14日主力资金净卖出1.19亿元
证券之星 · 10-15
康希诺(688185)10月14日主力资金净卖出1.19亿元
康希诺(688185)10月13日主力资金净卖出1.20亿元
证券之星 · 10-14
康希诺(688185)10月13日主力资金净卖出1.20亿元
破发股康希诺跌7.76% 2020年上市募52亿元中信证券保荐
中金财经 · 10-12
破发股康希诺跌7.76% 2020年上市募52亿元中信证券保荐
今日涨停!688185回应mRNA热点:胶质母细胞瘤等肿瘤疫苗仍在早期研发
同花顺 · 09-30
今日涨停!688185回应mRNA热点:胶质母细胞瘤等肿瘤疫苗仍在早期研发
康希诺最新公告:正在进行mRNA预防用疫苗及治疗性生物制品的开发以及相关递送系统的开发
证券之星 · 09-30
康希诺最新公告:正在进行mRNA预防用疫苗及治疗性生物制品的开发以及相关递送系统的开发
创新药一路狂涨!688185,直线20cm涨停
东方财富网 · 09-30
创新药一路狂涨!688185,直线20cm涨停
港股午评|恒生指数早盘跌0.04% CRO概念股涨幅居前
智通财经 · 09-30
港股午评|恒生指数早盘跌0.04% CRO概念股涨幅居前
A股午评:沪指早间涨0.27%,超2300只个股上涨,房地产股探底回升
格隆汇 · 09-30
A股午评:沪指早间涨0.27%,超2300只个股上涨,房地产股探底回升
康希诺盘中涨停
东方财富网 · 09-30
康希诺盘中涨停
康希诺生物(688185)9月28日主力资金净买入6635.44万元
证券之星 · 09-29
康希诺生物(688185)9月28日主力资金净买入6635.44万元
康希诺生物(688185)9月24日主力资金净卖出1.62亿元
证券之星 · 09-25
康希诺生物(688185)9月24日主力资金净卖出1.62亿元
康希诺:公司拥有合作品种商业化后的大中华区权益
证券之星 · 09-21
康希诺:公司拥有合作品种商业化后的大中华区权益
康希诺扣非连亏4年半 2020年上市募52亿元中信证券保荐
中金财经 · 09-17
康希诺扣非连亏4年半 2020年上市募52亿元中信证券保荐
康希诺:关于向2025年A股限制性股票激励计划激励对象授予部分预留限制性股票的公告
同花顺 · 09-16
康希诺:关于向2025年A股限制性股票激励计划激励对象授予部分预留限制性股票的公告
破发股康希诺跌3.75% 2020年上市募52亿元中信证券保荐
中金财经 · 09-09
破发股康希诺跌3.75% 2020年上市募52亿元中信证券保荐
每周股票复盘:康希诺(688185)H股/A股股本无变动
证券之星 · 09-06
每周股票复盘:康希诺(688185)H股/A股股本无变动
破发股康希诺跌6.76% 2020年上市募52亿元中信证券保荐
中金财经 · 09-04
破发股康希诺跌6.76% 2020年上市募52亿元中信证券保荐
加载更多
公司概况
公司名称:
康希诺生物股份公司
所属行业:
医药制造业
上市日期:
2020-08-13
主营业务:
康希诺生物股份公司的主营业务是研发、生产和商业化符合中国及国际标准的创新型疫苗。公司的主要产品是脑膜炎球菌结合疫苗、肺炎球菌结合疫苗、组分百白破疫苗、重组脊髓灰质炎疫苗等。公司已被国家工业和信息化部评为专精特新“小巨人”企业,入选天津市猎豹企业。公司自主研发的“多糖蛋白结合疫苗关键技术及产业化”项目荣获天津市科学技术进步一等奖。获奖项目所攻克的核心为多糖蛋白结合技术,是当前全球领先的疫苗技术之一。
发行价格:
209.71
{"stockData":{"symbol":"688185","market":"SH","secType":"STK","nameCN":"康希诺","latestPrice":74.3,"timestamp":1792652400000,"preClose":79.67,"halted":0,"volume":7603420,"delay":0,"changeRate":-0.0674,"floatShares":113999999,"shares":247000000,"eps":0.1645,"marketStatus":"已收盘","change":-5.37,"latestTime":"10-22 15:00:00","open":78.71,"high":80.95,"low":73.97,"amount":581000000,"amplitude":0.0876,"askPrice":74.3,"askSize":71,"bidPrice":74.27,"bidSize":101,"shortable":0,"etf":0,"ttmEps":0.1645,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792719000000},"marketStatusCode":5,"adr":0,"adjPreClose":79.67,"symbolType":"stock_kcb","openAndCloseTimeList":[[1792632600000,1792639800000],[1792645200000,1792652400000]],"highLimit":87.64,"lowLimit":71.7,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":247043801,"isCdr":false,"pbRate":3.69,"roa":"--","peRate":451.671733,"roe":"--","epsLYR":0.11,"committee":-0.493289,"marketValue":18355000000,"turnoverRate":0.0665,"status":1,"afterMarket":{"amount":52010,"volume":700,"close":74.3,"buyVolume":0,"sellVolume":10163,"time":1792654437746,"indexStatus":"已收盘 10-22 15:30:00","preClose":79.67},"hkstockBrief":{"symbol":"06185","market":"HK","secType":"STK","nameCN":"康希诺生物","latestPrice":28.94,"timestamp":1792656515008,"preClose":30.1,"halted":0,"volume":2467146,"delay":0,"premium":"-66.84"},"floatMarketCap":8498000000},"requestUrl":"/m/hq/s/688185","defaultTab":"news","newsList":[{"id":"2677072937","title":"破发股康希诺跌6.74% 2020年上市募52亿元中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2677072937","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677072937?lang=zh_cn&edition=full","pubTime":"2026-10-22 16:06","pubTimestamp":1792656362,"startTime":"0","endTime":"0","summary":"中国经济网北京10月22日讯 康希诺 今日收报74.30元,跌幅6.74%。该股目前处于破发状态。 康希诺于2020年8月13日在上交所科创板上市,发行数量为2480万股,发行价格209.71元/股,保荐机构为中信证券,保荐代表人为焦延延、马可;联席主承销商为中金公司,副主承销商为渤海证券。 康希诺首次公开发行股票发行费用为2.21亿元,其中,保荐及承销费用2.05亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261022/32405299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU1781817850.SGD","LU1997244956.HKD","LU0405327148.USD","06030","600030","LU1720050803.USD","LU2289578879.USD","LU1064131003.USD","LU1328615791.USD","BK0012","688185","BK1564","LU1997245177.USD","LU1580142542.USD","LU1655091616.SGD","LU1794554557.SGD","LU1146622755.USD","LU1997245094.SGD","LU0405327494.USD","BK1516","LU2580892789.USD","BK0239","BK1147","LU2580892862.HKD","IPOS","LU1255011170.USD","BK0183","BK0188","LU1820825898.SGD","BK0028","LU2495084118.USD","BK0276","BK1521","LU2148510915.USD","LU1064130708.USD","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676665765","title":"康希诺:定期报告截止日及其后的股东人数披露不早于当期定期报告的披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2676665765","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676665765?lang=zh_cn&edition=full","pubTime":"2026-10-20 16:45","pubTimestamp":1792485919,"startTime":"0","endTime":"0","summary":"证券之星消息,康希诺10月20日在投资者关系平台上答复投资者关心的问题。如您有查阅公司股东人数的需求,可于公司定期报告披露后再次提问;或向公司投资者关系邮箱发送邮件取得进一步联系。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000024957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676637690","title":"康希诺(688185)10月19日主力资金净卖出9719.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676637690","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676637690?lang=zh_cn&edition=full","pubTime":"2026-10-20 08:30","pubTimestamp":1792456217,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月19日收盘,康希诺报收于80.06元,下跌3.44%,换手率8.15%,成交量9.32万手,成交额7.47亿元。近5日资金流向一览见下表:康希诺融资融券信息显示,融资方面,当日融资买入8308.23万元,融资偿还7848.64万元,融资净买入459.58万元。康希诺主营业务:创新疫苗的研发、生产及商业化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000005332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675375791","title":"康希诺(688185)10月14日主力资金净卖出1.19亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675375791","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675375791?lang=zh_cn&edition=full","pubTime":"2026-10-15 08:31","pubTimestamp":1792024271,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月14日收盘,康希诺报收于84.0元,下跌4.59%,换手率7.25%,成交量8.29万手,成交额7.11亿元。近5日资金流向一览见下表:康希诺融资融券信息显示,融资方面,当日融资买入4998.73万元,融资偿还8137.77万元,融资净偿还3139.05万元。康希诺主营业务:创新疫苗的研发、生产及商业化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500007161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675957613","title":"康希诺(688185)10月13日主力资金净卖出1.20亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675957613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675957613?lang=zh_cn&edition=full","pubTime":"2026-10-14 08:26","pubTimestamp":1791937609,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月13日收盘,康希诺报收于88.04元,下跌3.06%,换手率10.06%,成交量11.5万手,成交额10.1亿元。近5日资金流向一览见下表:康希诺融资融券信息显示,融资方面,当日融资买入1.02亿元,融资偿还8892.24万元,融资净买入1337.56万元。康希诺主营业务:创新疫苗的研发、生产及商业化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400007197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674487329","title":"破发股康希诺跌7.76% 2020年上市募52亿元中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2674487329","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674487329?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:12","pubTimestamp":1791796329,"startTime":"0","endTime":"0","summary":"中国经济网北京10月12日讯 康希诺 今日收报90.82元,跌幅7.76%。该股目前处于破发状态。 康希诺于2020年8月13日在上交所科创板上市,发行数量为2480万股,发行价格209.71元/股,保荐机构为中信证券,保荐代表人为焦延延、马可;联席主承销商为中金公司,副主承销商为渤海证券。 康希诺首次公开发行股票发行费用为2.21亿元,其中,保荐及承销费用2.05亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261012/32393790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU1997244956.HKD","BK1147","LU2289578879.USD","LU1328615791.USD","LU1064131003.USD","06030","688185","LU2148510915.USD","LU2495084118.USD","BK1521","LU1146622755.USD","LU1997245094.SGD","BK1516","LU1064130708.USD","BK0239","LU1781817850.SGD","IPOS","LU1720050803.USD","LU2580892862.HKD","BK1564","LU0405327494.USD","LU1580142542.USD","BK0183","BK0188","LU2580892789.USD","BK0196","LU1655091616.SGD","BK0028","LU1794554557.SGD","600030","LU1820825898.SGD","BK0276","LU0405327148.USD","LU1255011170.USD","BK0012","LU1997245177.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671678361","title":"今日涨停!688185回应mRNA热点:胶质母细胞瘤等肿瘤疫苗仍在早期研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2671678361","media":"同花顺","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671678361?lang=zh_cn&edition=full","pubTime":"2026-09-30 22:45","pubTimestamp":1790779500,"startTime":"0","endTime":"0","summary":"9月30日,康希诺(SH688185)涨停,当日收盘价达102.64元/股,市值254亿元。当日晚间,康希诺公告称,公司股票于2026年9月28日、9月29日及9月30日连续三个交易日内日收盘价格涨幅偏离值累计超 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260930/c680424439.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260930/c680424439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0239","159646","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671205420","title":"康希诺最新公告:正在进行mRNA预防用疫苗及治疗性生物制品的开发以及相关递送系统的开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2671205420","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671205420?lang=zh_cn&edition=full","pubTime":"2026-09-30 18:51","pubTimestamp":1790765462,"startTime":"0","endTime":"0","summary":"康希诺(688185.SH)发布股票交易异常波动公告,公司关注到近期市场上关于mRNA技术的发展,海外mRNA肿瘤疫苗临床阶段性数据发布或计划公开。mRNA平台是公司布局的技术平台之一,公司正在进行mRNA预防用疫苗及治疗性生物制品的开发,以及相关递送系统的开发。治疗领域方面,公司正在推进mRNA疫苗用于治疗胶质母细胞瘤、横纹肌肉瘤及宫颈癌等适应症的研发工作,以及InVivoCAR相关疗法的开发,目前均处于早期阶段。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000031654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159646","BK0239","688185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671057522","title":"创新药一路狂涨!688185,直线20cm涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2671057522","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671057522?lang=zh_cn&edition=full","pubTime":"2026-09-30 18:23","pubTimestamp":1790763780,"startTime":"0","endTime":"0","summary":"9日最后一个交易日,A股三大指数今日涨跌不一,截至收盘,上证指数涨0.31%,深证成指跌0.11%,创业板指跌0.23%,北证50涨0.7%,科创50指数跌2.51%。全市场成交额14500亿元,较上日放量285亿元,全市场超2800只个股下跌。创新药板块涨幅第一,康希诺触及20cm涨停,贝瑞基因、康辰药业、昭衍新药、奥赛康等多股涨停,三元基因、义翘神州涨超10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11134,202609303887817031.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11134,202609303887817031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["BK1161","BK1574","LNGR","06978","159992","688185","BK0239","IBBQ","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671222053","title":"港股午评|恒生指数早盘跌0.04% CRO概念股涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2671222053","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671222053?lang=zh_cn&edition=full","pubTime":"2026-09-30 12:00","pubTimestamp":1790740842,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,港股恒生指数跌0.04%,跌10个点,报24513点;恒生科技指数跌0.15%。港股早盘成交887亿港元。mRNA概念股涨幅居前。CRO概念股涨幅居前,BD高增叠加湿实验需求升温,行业景气度上行信号明确。泰格医药涨超4%,与迪安诊断签署战略合作协议,将围绕AI制药等多领域开展深度合作。地产港股盘中V型反转,万科企业一度跌超11%,午盘涨超2%。汇量科技涨超8%,AI Infra升级有望进一步提升算法效率。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502511.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07300","03115","BK4588","03037","LU0828237940.HKD","BK1518","WDNA","BK1521","03419","BK1574","BK1592","02833","GNOM","06127","000002","300347","06821","MCHmain","002821","LGHT","82800","BK1191","BK1576","BK1555","LU0326950275.SGD","03067","BK1137","BK4548","LU1188198961.HKD","01548","02837","688185","BK1198","BK1240","BK1206","03347","06802","09088","02723","BK4533","BK1613","MRNA","BK4532","07552","BK1594","09067","01787","BK4139","HHImain","07200","03423","BK1161","HK0000306701.USD","BK1507","03032","BK1544","URNJ","HSTECH","02202","BK1524","BK1590","HK0000306685.HKD","LU0181495838.USD","02362","07500","02800","603127","BK4501","HK0000320223.HKD","01164","00625","BK1586","01860","MRNY","BK4534","BK1178","BK4568","HK0000320264.USD","IE0034224299.USD","09115","BK1141","03033","LU0463099449.HKD","LU1831875114.USD","600547","03417","HSI","LU0244354667.USD","BK1515","06185","LU0140636845.USD","BK1583","MRNX","03088","BK4585","513600","BK4551","07226","83115","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671225002","title":"A股午评:沪指早间涨0.27%,超2300只个股上涨,房地产股探底回升","url":"https://stock-news.laohu8.com/highlight/detail?id=2671225002","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671225002?lang=zh_cn&edition=full","pubTime":"2026-09-30 11:35","pubTimestamp":1790739354,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0188","LU1655091616.SGD","06185","399006","IE00B0JY6N72.USD","LU1807302812.USD","BK0028","BK0187","LU1781817850.SGD","LU0072913022.USD","LU1226287529.USD","LU0067412154.USD","BK0012","BK0278","LU0501845795.SGD","LU1993786604.SGD","BK0201","BK0183","07234","000001","BK0196","BK0273","BK0239","BK0011","688185","BK0020","LU1580142542.USD","LU0880133367.SGD","BK0184","BK0053","600663","03147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671224919","title":"康希诺盘中涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2671224919","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671224919?lang=zh_cn&edition=full","pubTime":"2026-09-30 10:15","pubTimestamp":1790734500,"startTime":"0","endTime":"0","summary":"9月30日盘中科创板股康希诺涨停,截至09:38,股价报102.64元,成交5.77亿元,换手率5.16%,振幅19.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11134,202609303887514985.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11134,202609303887514985.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["688185","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671266951","title":"康希诺生物(688185)9月28日主力资金净买入6635.44万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671266951","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671266951?lang=zh_cn&edition=full","pubTime":"2026-09-29 08:17","pubTimestamp":1790641025,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月28日收盘,康希诺生物报收于86.5元,上涨5.99%,换手率9.1%,成交量10.4万手,成交额8.9亿元。近5日资金流向一览见下表:康希诺生物融资融券信息显示,融资方面,当日融资买入8488.95万元,融资偿还7080.37万元,融资净买入1408.58万元。康希诺生物主营业务:创新疫苗的研发、生产及商业化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900006987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1191","BK1574","BK1515","688185","06185","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670494419","title":"康希诺生物(688185)9月24日主力资金净卖出1.62亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670494419","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670494419?lang=zh_cn&edition=full","pubTime":"2026-09-25 08:29","pubTimestamp":1790296173,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月24日收盘,康希诺生物报收于81.61元,下跌4.27%,换手率8.81%,成交量10.08万手,成交额8.35亿元。近5日资金流向一览见下表:康希诺生物融资融券信息显示,融资方面,当日融资买入6225.43万元,融资偿还8899.21万元,融资净偿还2673.78万元。康希诺生物主营业务:创新疫苗的研发、生产及商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092500005227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","BK1191","BK1515","BK0239","BK1161","BK1574","06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669519691","title":"康希诺:公司拥有合作品种商业化后的大中华区权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2669519691","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669519691?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:12","pubTimestamp":1789981935,"startTime":"0","endTime":"0","summary":"证券之星消息,康希诺生物09月21日在投资者关系平台上答复投资者关心的问题。此外,康希诺在大中华区拥有的OCU400权益,是否已经覆盖目前Phase 3所涉及的广泛RP人群及相应适应症范围?康希诺生物回复:尊敬的投资人您好,公司已完成该合作候选药物的美国BLA申报前开发工作及PPQ工艺验证,BLA现场检查的相关准备工作正在进行中,公司拥有合作品种商业化后的大中华区权益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100021622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668164951","title":"康希诺扣非连亏4年半 2020年上市募52亿元中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2668164951","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668164951?lang=zh_cn&edition=full","pubTime":"2026-09-17 14:35","pubTimestamp":1789626902,"startTime":"0","endTime":"0","summary":"中国经济网北京9月17日讯 康希诺 近日披露2026年半年度报告。 康希诺于2020年8月13日在上交所科创板上市,发行数量为2480万股,发行价格209.71元/股,保荐机构为中信证券,保荐代表人为焦延延、马可;联席主承销商为中金公司,副主承销商为渤海证券。 康希诺首次公开发行股票募集资金总额为52.01亿元,扣除发行费用后,募集资金净额为49.79亿元。 康希诺首次公开发行股票发行费用为2.21亿元,其中,保荐及承销费用2.05亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260917/32372917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU0405327148.USD","LU2580892862.HKD","LU0405327494.USD","BK0012","BK1516","688185","IPOS","LU1794554557.SGD","LU1064130708.USD","BK1564","LU1997244956.HKD","LU1064131003.USD","LU1328615791.USD","LU1655091616.SGD","BK1521","06030","LU1820825898.SGD","BK0183","BK0196","LU1781817850.SGD","LU1997245094.SGD","LU1255011170.USD","600030","BK0028","LU2580892789.USD","LU1997245177.USD","LU1720050803.USD","LU1146622755.USD","BK0276","BK0239","LU2148510915.USD","LU2495084118.USD","LU1580142542.USD","LU2289578879.USD","BK0188","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667985393","title":"康希诺:关于向2025年A股限制性股票激励计划激励对象授予部分预留限制性股票的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2667985393","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667985393?lang=zh_cn&edition=full","pubTime":"2026-09-16 20:39","pubTimestamp":1789562340,"startTime":"0","endTime":"0","summary":" 证券日报网讯 9月16日,康希诺发布公告称,公司于2026年9月16日根据2025年第一次临时股东大会授权召开第三届董事会第五次临时会议,审议通过相关议案,以41.2 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260916/c679982678.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260916/c679982678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["399300","83130","BK0239","688185","03188","82846","BK1147","03130","159982","02827","83188","02846","07233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666583218","title":"破发股康希诺跌3.75% 2020年上市募52亿元中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2666583218","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666583218?lang=zh_cn&edition=full","pubTime":"2026-09-09 15:54","pubTimestamp":1788940444,"startTime":"0","endTime":"0","summary":"中国经济网北京9月9日讯 康希诺 今日收报68.82元,跌幅3.75%。该股目前处于破发状态。 康希诺于2020年8月13日在上交所科创板上市,发行数量为2480万股,发行价格209.71元/股,保荐机构为中信证券,保荐代表人为焦延延、马可;联席主承销商为中金公司,副主承销商为渤海证券。 康希诺首次公开发行股票发行费用为2.21亿元,其中,保荐及承销费用2.05亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260909/32364702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688185","BK1564","BK0012","LU1328615791.USD","LU2580892862.HKD","BK1521","LU1720050803.USD","LU2495084118.USD","BK0276","LU2148510915.USD","LU1794554557.SGD","BK0183","LU1064131003.USD","LU2289578879.USD","LU1146622755.USD","BK1147","LU1064130708.USD","BK0196","LU1997244956.HKD","BK0239","LU1655091616.SGD","BK1516","600030","BK0028","LU1255011170.USD","BK0188","LU0405327494.USD","IPOS","LU1781817850.SGD","LU0405327148.USD","LU1997245177.USD","LU1820825898.SGD","LU1580142542.USD","LU1997245094.SGD","LU2580892789.USD","06030"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665336538","title":"每周股票复盘:康希诺(688185)H股/A股股本无变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2665336538","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665336538?lang=zh_cn&edition=full","pubTime":"2026-09-06 01:14","pubTimestamp":1788628452,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总:康希诺H股和A股的已发行股份及注册资本本月无变动公司公告汇总:H股类别满足港交所公众持股量要求公司公告汇总:2025年A股限制性股票激励计划涉及2,054,600股,本月未新增发行公司公告汇总康希诺生物股份公司截至2026年8月31日的证券变动月报表显示,公司H股和A股的法定注册资本、已发行股份及库存股份数目均无变动。另有2025年A股限制性股票激励计划,涉及2,054,600股限制性股票,本月未新增发行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["07233","02827","83188","03188","BK0239","399300","BK1147","83130","82846","03130","02846","688185","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664380700","title":"破发股康希诺跌6.76% 2020年上市募52亿元中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2664380700","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664380700?lang=zh_cn&edition=full","pubTime":"2026-09-04 16:46","pubTimestamp":1788511569,"startTime":"0","endTime":"0","summary":"中国经济网北京9月4日讯 康希诺 今日收报68.93元,跌幅6.76%。该股目前处于破发状态。 康希诺于2020年8月13日在上交所科创板上市,发行数量为2480万股,发行价格209.71元/股,保荐机构为中信证券,保荐代表人为焦延延、马可;联席主承销商为中金公司,副主承销商为渤海证券。 康希诺首次公开发行股票发行费用为2.21亿元,其中,保荐及承销费用2.05亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260904/32360411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0012","BK1516","LU1580142542.USD","LU1328615791.USD","LU2289578879.USD","LU1820825898.SGD","LU0405327494.USD","06030","BK0028","LU1997244956.HKD","IPOS","BK1521","LU1064130708.USD","BK0239","LU0405327148.USD","BK0196","LU1146622755.USD","LU1997245094.SGD","BK1147","BK0188","LU1997245177.USD","LU2580892789.USD","LU1655091616.SGD","LU2580892862.HKD","LU1064131003.USD","688185","600030","BK0276","LU2495084118.USD","LU2148510915.USD","BK0183","LU1794554557.SGD","LU1255011170.USD","BK1564","LU1720050803.USD","LU1781817850.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792695248166,"stockEarnings":[{"period":"1week","weight":-0.1016},{"period":"1month","weight":-0.0682},{"period":"3month","weight":0.5367},{"period":"6month","weight":0.1335},{"period":"1year","weight":0.0008},{"period":"ytd","weight":0.1822}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0744},{"period":"3month","weight":-0.0409},{"period":"6month","weight":-0.1034},{"period":"1year","weight":-0.0653},{"period":"ytd","weight":-0.0783}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康希诺生物股份公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"15985人(较上一季度减少2.99%)","perCapita":"7155股","listingDate":"2020-08-13","address":"天津市东丽区经济技术开发区西区南大街185号西区生物医药园四层401-420","registeredCapital":"24704万元","survey":" 康希诺生物股份公司的主营业务是研发、生产和商业化符合中国及国际标准的创新型疫苗。公司的主要产品是脑膜炎球菌结合疫苗、肺炎球菌结合疫苗、组分百白破疫苗、重组脊髓灰质炎疫苗等。公司已被国家工业和信息化部评为专精特新“小巨人”企业,入选天津市猎豹企业。公司自主研发的“多糖蛋白结合疫苗关键技术及产业化”项目荣获天津市科学技术进步一等奖。获奖项目所攻克的核心为多糖蛋白结合技术,是当前全球领先的疫苗技术之一。","listedPrice":209.71},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康希诺,688185,康希诺股票,康希诺股票老虎,康希诺股票老虎国际,康希诺行情,康希诺股票行情,康希诺股价,康希诺股市,康希诺股票价格,康希诺股票交易,康希诺股票购买,康希诺股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}